GlycoMimetics Inc

NASDAQ:GLYC   3:59:44 PM EDT
2.82
-0.06 (-2.08%)
Products

FDA Grants GlycoMimetics Rare Pediatric Disease Designation For Rivipansel

Published: 10/05/2020 20:51 GMT
GlycoMimetics Inc (GLYC) - FDA Grants Glycomimetics Rare Pediatric Disease Designation for Rivipansel for Treatment of Sickle Cell Disease.
Glycomimetics - Plan to Roll Out Full Data Set From Phase 3 Reset Program at Upcoming Medical Meetings, Based on Acceptance of Abstract Submissions.